Noel W. Clarke

机构：Salford Royal NHS Foundation Trust, University of Manchester, Salford Royal Hospital, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust · ORCID：0000-0001-7776-8059

发表论文 686 篇 · 总被引 26680 次 · h-index 80

代表论文

• Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study (2025 · Annals of Oncology · 被引 37)
• Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers (2025 · Cell · 被引 28)
• External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol (2025 · The Lancet Digital Health · 被引 19)
• Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data (2025 · European Urology · 被引 16)
• Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation (2025 · BMJ Oncology · 被引 10)
• Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation (2025 · Targeted Oncology · 被引 9)